SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-08-050163
Filing Date
2008-08-28
Accepted
2008-08-27 19:15:40
Documents
7
Period of Report
2008-08-27

Document Format Files

Seq Description Document Type Size
1 v125075_6k.htm 6-K 20460
2 v125075_ex99-1.htm EX-99.1 10464
3 GRAPHIC ex99-1logo.jpg GRAPHIC 9053
4 v125075_ex99-2.htm EX-99.2 73579
5 GRAPHIC ex99-2logo.jpg GRAPHIC 13958
6 GRAPHIC ex99-2logo1.jpg GRAPHIC 5737
7 v125075_ex99-3.htm EX-99.3 35232
  Complete submission text file 0001144204-08-050163.txt   181171
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 081043080
SIC: 2834 Pharmaceutical Preparations